Thymic Peptides in Immunology Research: Thymosin Alpha-1 and Thymalin

For in-vitro and laboratory research only. The compounds below are research-grade preparations; nothing below constitutes medical guidance.

The thymus gland produces a family of peptides involved in T-cell maturation. Two thymic preparations appear frequently in research-supply catalogs: Thymosin Alpha-1, a single defined 28-amino-acid peptide, and Thymalin, a peptide-fraction preparation extracted from thymic tissue. They are distinct molecules with overlapping research literature. Available as Thymosin Alpha-1 5mg and Thymalin 10mg.

Thymosin Alpha-1

Thymosin Alpha-1 (Tα1) is a 28–amino-acid acetylated peptide originally isolated from thymosin fraction 5. It is a single, defined molecule with a known sequence and CAS number. Published research has examined its activity in T-cell function, dendritic-cell maturation, and antiviral-immunity models. The clinical compound thymalfasin is the same molecule and has approved therapeutic use in some jurisdictions.

Thymalin

Thymalin is a thymus-derived peptide-fraction preparation, not a single defined peptide. Russian research literature has examined Thymalin in immunomodulation and aging-research contexts. Because it is a fraction rather than a single molecule, COA verification is necessarily different: rather than a defined sequence, the COA reports the peptide-content profile and source/production process.

Mechanisms reported in published literature

Thymosin Alpha-1

• Modulation of T-helper-1 and T-helper-2 cytokine balance in cell-culture assays.
• Activation of Toll-like receptor 9 signaling in dendritic cells.
• Antiviral effects in published preclinical models for hepatitis viruses.

Thymalin

• Changes in T-cell subpopulation distribution in aged-rodent studies.
• Cytokine-profile modulation in stress-model literature.

Related research peptides

For other immunology-relevant peptide research, see literature on LL-37 (a cathelicidin) and VIP 5mg (vasoactive intestinal peptide), both with documented immunomodulatory mechanisms in published cell-culture work.

Handling and storage

Thymosin Alpha-1 is supplied lyophilized as a single defined peptide and follows standard peptide-handling practice — see our peptide storage guide. Thymalin is also lyophilized; because it is a fraction, batch-to-batch consistency is more dependent on the producer’s manufacturing process, making lot-level COA review particularly important.

What to verify on the COA

Thymosin Alpha-1

• Full 28–amino-acid sequence with the N-terminal acetylation explicitly noted.
• Purity ≥98% by HPLC.
• Mass spec match for ~3108 Da.

Thymalin

• Peptide-fraction profile / total peptide content.
• Source-tissue and production-process declaration.
• Microbial-contamination screening relevant to a tissue-derived preparation.

See how to read a peptide COA for general field-level guidance.

Reminder: All material is summarized from preclinical research literature for laboratory and educational use. Products are not intended for human consumption.